Sanofi SA:企業のM&A・事業提携・投資動向

◆英語タイトル:Sanofi SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2118
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:141
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanofi SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Sanofi SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sanofi SA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Sanofi SA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Sanofi SA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Sanofi SA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Sanofi SA and its subsidiaries since 2007.
- Information about key financial and legal advisors for Sanofi SA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Sanofi SA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 20
Corporate Venturing – Overview 20
Corporate Venturing – Deal reports 21
PARTNERSHIP 24
Partnership – Overview 24
Partnership – Deal reports 25
CAPITAL RAISING 97
Capital Raising – Overview 97
Capital Raising – Deal reports 98
DIVESTMENTS 114
Divestments – Overview 114
Divestments – Deal reports 115
APPENDIX 131
Contact Us 131
About MarketLine Financial Deals Database 131
Deal Definition and Methodology 133
About MarketLine 140

List of Tables
Table 1: Sanofi M&A volume and value trend (2014-YTD2018)
Table 2: Sanofi M&A activity by geography (2014-YTD2018)
Table 3: Sanofi corporate venturing volume and value trend (2014-YTD2018)
Table 4: Sanofi corporate venturing by geography (2014-YTD2018)
Table 5: Sanofi partnership volume and value trend (2014-YTD2018)
Table 6: Sanofi partnership trend by key deal type (2014-YTD2018)
Table 7: Sanofi capital raising volume and value trend (2014-YTD2018)
Table 8: Sanofi capital raising by deal type (2014-YTD2018)
Table 9: Sanofi divestments volume and value trend (2014-YTD2018)
Table 10: Sanofi divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Sanofi M&A volume and value trend (2014-YTD2018)
Figure 2: Sanofi M&A activity by geography (2014-YTD2018)
Figure 3: Sanofi corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Sanofi corporate venturing by geography (2014-YTD2018)
Figure 5: Sanofi partnership volume and value trend (2014-YTD2018)
Figure 6: Sanofi partnership trend by key deal type (2014-YTD2018)
Figure 7: Sanofi capital raising volume and value trend (2014-YTD2018)
Figure 8: Sanofi capital raising by deal type (2014-YTD2018)
Figure 9: Sanofi divestments volume and value trend (2014-YTD2018)
Figure 10: Sanofi divestments by geography (2014-YTD2018)

★海外企業調査レポート[Sanofi SA:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CSX Corp (CSX):企業の財務・戦略的SWOT分析
    CSX Corp (CSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a provider of in revenue cycle management. The company offers patient engagement and SaaS-based solutions. Its portfolio of services includes Health Information Management (HIM), patient care, patient engagement, coding and Clinical Docu …
  • Sanquin Blood Supply Foundation:医療機器:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • RiskSense Inc:企業の戦略的SWOT分析
    RiskSense Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Eu Yan Sang International Ltd:企業の戦略的SWOT分析
    Eu Yan Sang International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • Regenicin Inc (RGIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • S.C. Termoelectrica SA:企業の戦略的SWOT分析
    S.C. Termoelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Forty Seven Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Cineplex Inc:企業の戦略・SWOT・財務情報
    Cineplex Inc - Strategy, SWOT and Corporate Finance Report Summary Cineplex Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • First Bank of Nigeria Ltd:企業の戦略・SWOT・財務情報
    First Bank of Nigeria Ltd - Strategy, SWOT and Corporate Finance Report Summary First Bank of Nigeria Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • LGT Bank Ltd.:企業の戦略・SWOT・財務分析
    LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • DMG America LLC:企業の戦略的SWOT分析
    DMG America LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • GKN plc:企業の戦略・SWOT・財務情報
    GKN plc - Strategy, SWOT and Corporate Finance Report Summary GKN plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Colorado Farm Bureau Mutual Insurance Co.:企業の戦略・SWOT・財務情報
    Colorado Farm Bureau Mutual Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary Colorado Farm Bureau Mutual Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Humanwell Healthcare (Group) Co Ltd (600079):医療機器:M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • Liberty Media Corp (BATRA):企業の財務・戦略的SWOT分析
    Liberty Media Corp (BATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Dine Brands Global, Inc. (DIN):企業の財務・戦略的SWOT分析
    Dine Brands Global, Inc. (DIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Union Jack Oil plc (UJO):石油・ガス:M&Aディール及び事業提携情報
    Summary Union Jack Oil plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆